Thalidomide, advertised in the 1950s as a safe drug for morning sickness in pregnancy and as a sedative, created an epidemic of 15,000 babies worldwide with missing limbs (1). As we discovered later, thalidomide also caused other developmental disabilities including mental retardation and autism (2, 3) . Graphic depictions of children deformed by thalidomide aroused the public and its elected representatives and provoked new laws and regulations designed to prevent a recurrence. A birth defects surveillance program was put into place at the Centers for Disease Control (CDC) in Atlanta, Georgia, and continues to this day. New drugs now undergo extended testing for their potential to induce birth defects.
Today, 40 years later, we are coming to realize that the thalidomide tragedy was not an exception, but, rather, a warning. We have come to understand that chemicals in the environment can cause a wide range of developmental disabilities in children, and that anatomic malformations are only the most obvious. Current concerns especially focus on the concept that certain chemicals can cause clinical and subclinical deficits in neurobehavioral development through injury to the fetal brain. The implications of small shifts in intelligence quotient score and a slightly increased tendency to aggression are not so easily conveyed or grasped as a picture of deformed limbs. However, recognition of the importance of such changes is gathering momentum and is documented in this monograph.
A prime motivating force is the realization that we know the causes of fewer than 25% of neurodevelopmental disabilities. These disabilities, including dyslexia, attention deficit hyperactivity disorder (ADHD), intellectual retardation, and autism, affect an estimated 3-8% of the 4 (5,6). Polychlorinated biphenyls (PCBs) are distributed widely in the environment and cross the placenta to cause in utero injury to the developing brain (7, 8) . Organic mercury compounds are among the most potent developmental neurotoxicants (9, 10) . Certain pesticides are documented to induce prenatal brain injury in rodent species and to result in functional deficits (11, 12) ; the possibility that they produce similar effects in humans helped spur passage, in 1996, ofthe Food Quality Protection Act (13) . Little information on possible toxic potential is available for the 80,000 chemicals registered today with the U.S. Environmental Protection Agency (EPA). Of the 3,000 chemicals produced or imported at over 1 million pounds a year, only 43% have received even minimal toxicologic assessment, and a mere 23% have been tested to determine whether they have the potential to cause developmental damage (14) . In the words of pediatrician Herbert L. Needleman, "We are conducting a vast toxicologic experiment in our society, in which our children and our children's children are the experimental subjects" (15) .
We are faced with two major unanswered questions. First, to what extent do chemicals in the environment cause neurodevelopmental disabilities or other developmental disorders? Second, which chemicals in the environment in addition to lead, PCBs, and methyl mercury can cause neurodevelopmental disabilities? These are critical questions to address and resolve, because disabilities arising from exposure to toxic chemicals should be preventable.
The articles published in this monograph reflect the mounting concern that for too long we have neglected the possibility that environmental chemicals contribute to developmental disabilities in our children. Most of these reports are culled from two major conferences held in 1998 and 1999 devoted to the question of how children's neurobehavioral development is influenced by the chemical environment.
The first of these conferences, Health (17) , the "Green Book," which is available to pediatricians throughout the Americas.
Children's environmental health has climbed to a critical position as we launch the new millennium. This monograph marks a significant milestone in the evolution of this emerging discipline.
